Gitlife Biotech Appoints Beatrix Ellis as CEO
GitLife Biotech Ltd., is pleased to announce the appointment of Beatrix Ellis as its new Chief Executive Officer. Beatrix Ellis brings extensive experience in commercial strategy and a proven record in business development and capital raising, making her a strong fit to guide GitLife’s next phase of growth. She will oversee the company’s initiatives to […]
GitLife Biotech and NCIMB Secure Innovate UK Funding to Advance Synthetic Biology Therapeutics
GitLife Biotech is excited to announce the receipt of Innovate UK funding for the development of groundbreaking therapeutic solutions, in collaboration with NCIMB Ltd. This partnership aims to leverage synthetic biology and live bacteria to create new health-enhancing treatments. Innovate UK Funding Boost The Innovate UK grant supports a 12-month project focused on using GitLife’s […]
Introduction to GitLife Biotech
GitLife Biotech is at the forefront of synthetic biology, offering groundbreaking solutions that enhance the integrity and traceability of biological assets. Specialising in engineering biology, cell engineering, DNA barcoding, and comprehensive biological asset management, GitLife technology aligns with the objective of facilitating transparency essential for future advancements of engineering biology and intellectual property right management. […]
